This compound is a hydrochloride salt form of a key pharmaceutical intermediate used in the manufacturing of rivaroxaban. It features a complex structure with an oxazolidinone ring and a morpholinone group, indicating its role in selective synthesis pathways.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 898543-06-1
(S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one
pharmaceutical intermediate
2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene
pharmaceutical intermediate
6-Bromo-1H-indazole-4-carbonitrile
pharmaceutical intermediate
Methyl 5-bromo-1H-indazole-7-carboxylate
pharmaceutical intermediate
1H-Indazole-3,7-dicarboxylic acid 7-methyl ester
pharmaceutical intermediate
4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholin-3-one;hydrochloride
ITMQDYQHNKXERQ-YDALLXLXSA-N
C1COCC(=O)N1C2=CC=C(C=C2)N3C[C@@H](OC3=O)CN.Cl